Patent details
EP1983984
Title:
TUBEROUS SCLEROSIS TREATMENT
Basic Information
- Publication number:
- EP1983984
- PCT Application Number:
- EP2007000818
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP077114171
- PCT Publication Number:
- WO2007088034
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TUBEROUS SCLEROSIS TREATMENT
- French Title of Invention:
- TRAITEMENT DE LA SCLEROSE TUBEREUSE
- German Title of Invention:
- BEHANDLUNG VON TUBERÖSER SKLEROSE
- SPC Number:
-
Dates
- Filing date:
- 31/01/2007
- Grant date:
- 07/03/2018
- EP Publication Date:
- 29/10/2008
- PCT Publication Date:
- 09/08/2007
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/03/2018
- EP B1 Publication Date:
- 07/03/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 31/01/2027
- Renunciation date:
- Revocation date:
- 31/10/2023
- Annulment date:
Owner
- From:
- 26/05/2023
-
-
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
History of Owners
- From:
- 13/03/2019
- To:
- 26/05/2023
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- From:
- 13/03/2019
- To:
- 16/02/2023
- Name:
- NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
- From:
- 28/02/2018
- To:
- 13/03/2019
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- STUMM, Michael
- Address:
- Switzerland (CH)
2
- Name:
- BERG, William
- Address:
- United States (US)
3
- Name:
- BENEDETTO, John
- Address:
- United States (US)
4
- Name:
- LANE, Heidi
- Address:
- Switzerland (CH)
5
- Name:
- SELLERS, William
- Address:
- United States (US)
6
- Name:
- ELMROTH, Ingrid
- Address:
- Switzerland (CH)
7
- Name:
- LEBWOHL, David
- Address:
- United States (US)
Licencee
- Name:
- N.V. Novartis Pharma S.A.
- From:
- 27/03/2019
- Address:
- Medialaan 40, 1800, Vilvoorde, Belgium (BE)
- To:
Priority
1
- Priority Number:
- 0602123
- Priority Date:
- 02/02/2006
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 0603568
- Priority Date:
- 22/02/2006
- Priority Country:
- United Kingdom (GB)
3
- Priority Number:
- 0604593
- Priority Date:
- 07/03/2006
- Priority Country:
- United Kingdom (GB)
4
- Priority Number:
- 0605760
- Priority Date:
- 22/03/2006
- Priority Country:
- United Kingdom (GB)
5
- Priority Number:
- 0609698
- Priority Date:
- 16/05/2006
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
-
A61K 31/351;
A61K 31/365;
A61K 31/436;
A61P 25/00;
A61P 35/00;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2019/05
- Publication date:
- 11/04/2019
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- MED
- Bulletin edition number:
- 2019/06
- Publication date:
- 06/05/2019
- Description:
- Section K : Modifications and recordals into the register
3
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2023/03
- Publication date:
- 01/03/2023
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
4
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2024/03
- Publication date:
- 05/02/2024
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law)
Renunciation to a patent or supplementary protection certificate (Art. 72 of the law)
Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 201810
- Publication date:
- 07/03/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201902
- Publication date:
- 09/01/2019
- Description:
- Opposition procedure started
3
- Issue number:
- 202404
- Publication date:
- 24/01/2024
- Description:
- Revocation of the European patent
4
- Issue number:
- 202326
- Publication date:
- 28/06/2023
- Description:
- Transfer of Rights
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20190000121A
- Date Registered:
- 13/03/2019
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
1
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
2
- Name:
- NOVARTIS INTERNATIONAL PHARMACEUTICAL AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Removed Pledgee
- Name:
-
- Address:
Licence
- Change Kind/ Decision Type:
- New licence registration
- Deed Number:
- RC20190000139J
- Date Registered:
- 27/03/2019
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
- Not Exclusive
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
-
- Country Code:
- Luxembourg (LU)
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Licencee(s)
- Name:
- N.V. Novartis Pharma S.A.
- Address:
- Medialaan 40, 1800, Vilvoorde, Belgium (BE)
Removed Pledgee
- Name:
-
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20230000064A
- Date Registered:
- 16/02/2023
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 12/01/2024
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM